Rovingaile Kriska (Rovika) Ponce
Boston University Chobanian & Avedisian School of Medicine


Pronouns: she/her/hers


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Thomas NJ, Luck C, Shlimon N, Ponce RK, Kosibaty Z, Okimoto RA. Mapping chromatin state and transcriptional response in CIC-DUX4 undifferentiated round cell sarcoma. bioRxiv. 2023 Oct 12. PMID: 37873100; PMCID: PMC10592754; DOI: 10.1101/2023.10.11.561932;
     
  2. Gupta N, Song H, Wu W, Ponce RK, Lin YK, Kim JW, Small EJ, Feng FY, Huang FW, Okimoto RA. The CIC-ERF co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progression. Elife. 2022 Nov 16; 11. PMID: 36383412; PMCID: PMC9668335; DOI: 10.7554/eLife.77072;
     
  3. Kim JW, Luck C, Wu W, Ponce RK, Lin YK, Gupta N, Okimoto RA. Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer. Cell Rep. 2022 Oct 04; 41(1):111443. PMID: 36198276; PMCID: PMC9674208; DOI: 10.1016/j.celrep.2022.111443;
     
  4. Ponce RKM, Thomas NJ, Bui NQ, Kondo T, Okimoto RA. WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma. JCI Insight. 2022 Mar 22; 7(6). PMID: 35315355; PMCID: PMC8986087; DOI: 10.1172/jci.insight.152293;
     
  5. Kim JW, Ponce RK, Okimoto RA. Capicua in Human Cancer. Trends Cancer. 2021 Jan; 7(1):77-86. PMID: 32978089; PMCID: PMC7770027; DOI: 10.1016/j.trecan.2020.08.010;
     
  6. Lin YK, Wu W, Ponce RK, Kim JW, Okimoto RA. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma. Proc Natl Acad Sci U S A. 2020 Aug 25; 117(34):20776-20784. PMID: 32788348; PMCID: PMC7456153; DOI: 10.1073/pnas.2009137117;
     
  7. Okimoto RA, Wu W, Nanjo S, Olivas V, Lin YK, Ponce RK, Oyama R, Kondo T, Bivona TG. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs. J Clin Invest. 2019 Jul 22; 129(8):3401-3406. PMID: 31329165; PMCID: PMC6668665; DOI: 10.1172/JCI126366;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 7 publications over 4 distinct years, with a maximum of 3 publications in 2022

YearPublications
20191
20202
20223
20231

Contact for Mentoring:

Ponce's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_